2002
DOI: 10.1002/nau.10034
|View full text |Cite
|
Sign up to set email alerts
|

Effects of β3‐adrenoceptor stimulation on prostaglandin E2–induced bladder hyperactivity and on the cardiovascular system in conscious rats

Abstract: The present results clearly demonstrated that the beta(3)-AR agonist prolonged the micturition interval without producing significant cardiovascular side effects. The human detrusor, like the rat detrusor, relaxes on beta(3)-AR stimulation. Provided that these results are valid in humans, selective beta(3)-AR agonists might be clinically useful for controlling a certain type of bladder overactivity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
44
0

Year Published

2006
2006
2012
2012

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 72 publications
(49 citation statements)
references
References 22 publications
5
44
0
Order By: Relevance
“…The ability of muscarinic antagonism to reduce MP in multiple species, including rats, is well documented (Angelico et al, 2005;Ney et al, 2008;McCafferty et al, 2009). Likewise, MI shortening and VV reduction in the SHR in response to muscarinic antagonism is consistent with previous rat studies (Igawa et al, 1993;Takeda et al, 2000Takeda et al, , 2002Ney et al, 2008). Overall, our urodynamic observations in response to muscarinic antagonism in the SHR are consistent with previous findings in cystometric studies of normal rats.…”
Section: Discussionsupporting
confidence: 91%
“…The ability of muscarinic antagonism to reduce MP in multiple species, including rats, is well documented (Angelico et al, 2005;Ney et al, 2008;McCafferty et al, 2009). Likewise, MI shortening and VV reduction in the SHR in response to muscarinic antagonism is consistent with previous rat studies (Igawa et al, 1993;Takeda et al, 2000Takeda et al, , 2002Ney et al, 2008). Overall, our urodynamic observations in response to muscarinic antagonism in the SHR are consistent with previous findings in cystometric studies of normal rats.…”
Section: Discussionsupporting
confidence: 91%
“…These results are consistent with previous reports that selective ␤ 3 -AR agonists improve bladder functions in rats with minimal effects on the cardiovascular system (Takeda et al, 2000b(Takeda et al, , 2002bKaidoh et al, 2002). Moreover, when we measured the plasma concentration of ritobegron in cynomolgus monkeys that had received on intraduodenal administration of 1, 3, or 10 mg/kg the maximum plasma values we obtained were 3.7 ϫ 10 Ϫ7 , 1.3 ϫ 10…”
Section: Discussionsupporting
confidence: 92%
“…D. Westfall, unpublished observations). In rat models, ␤ 3 -AR agonists have been shown to increase micturition interval in bladder instability evoked by cerebral infarction (Kaidoh et al, 2002), intravesical acetic acid or prostaglandin E 2 (Woods et al, 2001;Takeda et al, 2002b); inhibit sponta- jpet.aspetjournals.org neous intermicturition contractions in obstruction-induced bladder hyperplasia (Woods et al, 2001); and decrease the frequency of rhythmic bladder contractions (Takasu et al, 2007). ␤ 3 -AR-mediated bladder relaxation is also observed in the anesthetized ferret (Takeda et al, 2000).…”
Section: Discussionmentioning
confidence: 99%